| OAA0104 | Suppression of HIV-1 linked long non-coding RNAs in viremic HIV-1 positive individuals is associated with ongoing viral replication | Oral abstract session with live Q&A | A15 |
| OAA0105 | Assessing the T cell compartment of the extremely rare phenotype of elite control in children | Oral abstract session with live Q&A | A7 |
| OAA0106 | Virological and immunological evaluation of individuals with spontaneous persistent viral control without ART | Oral abstract session with live Q&A | A4 |
| OAA0202 | SMAC mimetic plus triple combination bispecific HIVxCD3 DART® molecules in SHIV.CH505-infected, ART-suppressed rhesus macaques | Oral abstract session with live Q&A | A18 |
| OAA0203 | Infection outcome in RT-SHIV infected macaques treated early with antiretroviral therapy alone or in combination with the TLR7 agonist vesatolimod | Oral abstract session with live Q&A | A21 |
| OAA0204 | Tyrosine kinase inhibitors promote antiviral resistance in CD4+ T cells against HIV-1 infection even after treatment withdrawal | Oral abstract session with live Q&A | A21 |
| OAA0205 | Combining a conditional suicide gene with CCR5 knockout for anti-HIV gene therapy | Oral abstract session with live Q&A | A20 |
| OAA0206 | Gene therapy with an anti-tat gene can strongly block HIV-1 transcription and virus replication in mouse models of infection | Oral abstract session with live Q&A | A20 |
| OAA0302 | Multivariant HIV-1 infection in infants with broadly neutralizing plasma antibodies: Implication for polyvalent vaccines | Oral abstract session with live Q&A | A28 |
| OAA0304 | Priming with DNA expressing trimeric V1V2A244 alters the immune hierarchy and favors the development of V2-specific HIV antibodies in rhesus macaques | Oral abstract session with live Q&A | A25 |